Creska adipose allograft derived from healthy subcutaneous fat tissue and contains live cells
FDA Compliant “Off the Shelf” Adipose derived Allograft. Regulated by the FDA as an HCT/P under 21 CFR Part 1271 and section 361 of the Public Health Service Act. Can be used anywhere in the body where fat or skin exists and can be administered via subcutaneous injection. Primary function is to provide protection, cushioning and lubrication. Secondary benefit has allowed providers to treat musculoskeletal, bone and cartilage disorders. Composed of the same cytokines and growth factors as Collagen, Elastin, Hyaluronic Acid, Proteins and Nano Particles. Comes to your office ready to use and is a faster, less risky, and virtually pain-free method to deliver positive patient outcomes compared to PRP, BMAC, UC, amniotic fluid, and Wharton’s Jelly.